An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

NCT07729579 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis (AK)

Interventions

DRUG: Investigational drug
DEVICE: Photodynamic therapy

Sponsor

Sun Pharmaceutical Industries Limited